![](/img/cover-not-exists.png)
PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
Ma, X.C., Shao, H., Meng, Q.Y., Haikui, S.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.596
Date:
May, 2019
File:
PDF, 378 KB
english, 2019